EC Number   |
Disease |
PubMed ID  |
Title of Publication |
Category |
Confidence Level |
|---|
   3.4.22.52 | Retinitis |
34078571 |
Evidence for the involvement of interleukin-1? during development of experimental cytomegalovirus retinitis in immunosuppressed mice. |
causal interaction
unassigned |
1
0 |
| 3.4.22.52 | Colitis |
34162146 |
Melatonin-mediated MT2 attenuates colitis induced by dextran sodium sulfate via PI3K/AKT/Nrf2/SIRT1/ROR?/NF-?B signaling pathways. |
causal interaction
therapeutic application
unassigned |
1
1
0 |
| 3.4.22.52 | Muscular Atrophy |
34319828 |
A semiautomated measurement of muscle fiber size using the Imaris software. |
causal interaction
unassigned |
2
0 |
| 3.4.22.52 | Breast Neoplasms |
34381117 |
Cleavage and activation of LIM kinase 1 as a novel mechanism for calpain 2-mediated regulation of nuclear dynamics. |
ongoing research
unassigned |
4
0 |
| 3.4.22.52 | Neurodegenerative Diseases |
34430716 |
Calpain-1 C2L domain peptide protects mouse hippocampus-derived neuronal HT22 cells against glutamate-induced oxytosis. |
unassigned |
0 |
| 3.4.22.52 | Heart Failure |
34524407 |
Calpain-2 Specifically Cleaves Junctophilin-2 at the Same Site as Calpain-1 but with Less Efficacy. |
causal interaction
therapeutic application
unassigned |
3
3
0 |
